Returns
Every filed return on the register. Filter, then open any return on lobbying.ie to read it in full.
Showing returns filed by Pfizer .
Filed returns
111
match these filters
| Period | Registrant | Policy area | Subject, as filed | Officials named | Link |
|---|---|---|---|---|---|
| Jan–Apr 2017 | Pfizer | Health | Pfizer is seeking reimbursement for a new treatment for metastatic breast cancer. Metastatic breast cancer is an advanced form of breast cancer where early detection unfortunately does not improve survival. Even if… (Matters involving public funds) | 8 | On lobbying.ie |
| Jan–Apr 2017 | Pfizer | Economic Development and Industry | The Companies Act 2014 allowed for a Ministerial exemption from changing a company name to include the word 'unlimited' in the company name. This change would create significant administrative and cost burden for five… (Legislation) | 17 | On lobbying.ie |
| Sep–Dec 2016 | Pfizer | Health | Metastatic breast cancer is an advanced form of breast cancer where early detection unfortunately does not improve survival. Even if diagnosed with early stage breast cancer, 30% of women will subsequently progress to… (Public policy or programme) | 6 | On lobbying.ie |
| Sep–Dec 2016 | Pfizer | Health | A Supply Agreement was negotiated in 2016 between the pharmaceutical industry and the state which provides 785m in savings over four years, ensures Irish on patent medicine prices are in line with 14 other EU countries (Public policy or programme) | 6 | On lobbying.ie |
| Sep–Dec 2016 | Pfizer | Taxation | Ireland has maintained a competitive corporate tax framework which is critical for international investment and this has become the subject of global and national debate and dialogue (Public policy or programme) | 6 | On lobbying.ie |
| Sep–Dec 2016 | Pfizer | Health | The Health (pricing and supply of medical goods) Act 2013 states that biologic medicines are out of scope for interchangeability. Biologic medicines are typically infusions and injections for diseases such as rheumatoid… (Legislation) | 5 | On lobbying.ie |
| May–Aug 2016 | Pfizer | Health | The Pfizer Health Index is an annual survey of public attitudes and awareness across a wide range of health issues and topics from personal health to health investment to personal concerns. Each year Pfizer publishes a… (Public policy or programme) | 1 | On lobbying.ie |
| May–Aug 2016 | Pfizer | Health | A Supply Agreement between the pharmaceutical industry and the goverment expired and a new Agreement was to be negotiated between the pharmaceutical industry and the DoH/State. (Public policy or programme) | 5 | On lobbying.ie |
| May–Aug 2016 | Pfizer | Health | raise awareness of metastatic breast cancer which is an advanced form of breast cancer where early detection unfortunately does not improve survival. Even if diagnosed early, 30% of women diagnosed with early breast… (Public policy or programme) | 4 | On lobbying.ie |
| Sep–Dec 2015 | Pfizer | EU Affairs | ‘On the Fight Against Breast Cancer in the European Union’ (Public policy or programme) | 1 | On lobbying.ie |
| Sep–Dec 2015 | Pfizer | EU Affairs | EU Regulation REACH - Registration, Evaluation, Authorisation and Restriction of Chemicals (Legislation) | 2 | On lobbying.ie |
Policy areas in these returns
| Public policy area | Filed returns | Share | Relative to the largest |
|---|---|---|---|
| Health | 56 | 50.5% | |
| EU Affairs | 21 | 18.9% | |
| Economic Development and Industry | 17 | 15.3% | |
| Taxation | 9 | 8.1% | |
| Trade | 4 | 3.6% | |
| Budgetary matters | 2 | 1.8% | |
| Energy and Natural Resources | 1 | 0.9% | |
| Transport | 1 | 0.9% |